CME Program Detail

Title: 12th Annual Neonatal Symposium: Improving Care and Outcomes for the High-Risk Preterm Infant
Date: Thu, Oct 26th, 2017
Time: 8:00 am - 12:45 pm
Location: Lang Auditorium

Statement of Need:
An extremely low birth weight baby (ELBW) born very prematurely and weighing between 401 and 1000 grams at birth is at the lower limits of viability. Diagnosis and treatment remain very difficult and challenging. Providers require updates on current recommendations and advances in management in order to further optimal patient outcomes. This 12th Annual NewYork-Presbyterian Queens Department of Pediatrics Neonatal Symposium will present new recommendations for stabilization of the ELBW infant in the delivery room, genetic causes of birth defects, evidence-based medicine contributing to standards of care, management of necrotizing enterocolitis (NEC), and considerations surrounding the use of donor milk in the Neonatal ICU. Participants will have the opportunity to interact with leaders in newborn medicine and to review current and important neonatal and perinatal topics of interest.

Target Audience:
Neonatologists, pediatricians, obstetricians, neonatal nurse practitioners, neonatal nurses, OB physician assistants, neonatal physician assistants

Speakers:

Wendy Chung, MD, PhD,
Kennedy Family Associate Professor Pediatrics in Medicine
Director of Precision Medicine
Irving Institute for Translational Research Columbia University

Haresh Kipalani, BM, MRCP, MSc
Professor of Pediatric, Perelman School of Medicine, University of Pennsylvania
Program Director, Newborn and Infant Chronic Lung Disease Program
Division of Neonatology, Children's Hospital of Philadelphia

Akhil Maheshwari, MD
Professor of Pediatrics, Molecular Medicine and Public Health
Pamela and Leslie Muma Endowed Chair in Neonatology
Chief Division of Neonatology
Assistan Dean, Graduate Medical Education
Morsani College of Medicine, USF Health

Marianne Garland, MD
Associate Professor of Clincal Pediatrics
Columbia University College of Physicians & Surgeons
Medical Director, NICU Lactation Program
Columbia University Medical Center
Disclosures: None

Moderators:

Pinchi S. Srinivasan, MD, MBA, FAAP
Associate Professor of Clinical Pediatrics
Weill Cornell Medical College
Director of Neonatology, NewYork-Presbyterian Queens

Objectives:

• Discuss genetic diagnosis of birth defects.
• Review evidence-based medicine contributing to standards of care in Neonatology.
• Interpret and reflect upon the most recent literature on NEC with an expert in this rapidly advancing field.
• Discuss considerations for use of donor milk in NICU.

Schedule:

8:00-8:45 am Registration and Continental Breakfast
8:45-9:00am Welcome/Introductory Remarks
9:00-9:45am Genetic Causes of Broken Hearts and Other Birth Defects - Wendy Chung, MD, PhD
9:45-10:30am When has Enough Evidence Accumulated to Make for a Standard of Care? Haresh Kirpalani, BM, MRCP, FRCP, MSc
10:30-10:45am Break
10:45-11:30am Update on NEC in the New Millenium - Akhil Maheshwari, MD
11:30-12:15pm Got Milk: Donor Milk in the Neonatal ICU - Marianne Garland, MD
12:15-12:45 Questions and Answers/Closing Remarks

Accreditation
New York Hospital Queens is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.

New York Hospital Queens designates this Live Activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement
The Medical Society of The State of New York relies upon planners and faculty participants in its CME activities to provide educational information that is objective and free of bias. In this spirit and in accordance with the guidelines of MSSNY and the ACCME, all speakers and planners for CME activities must disclose any relevant financial relationships with commercial interests whose products, devices or services may be discussed in the content of a CME activity, that might be perceived as a real or apparent conflict of interest. Any discussion of investigational or unlabeled uses of a product will be identified.

<< Back to Programs List

<< Back to Program Archive